Work

A randomized phase II trial of medical cannabis to reduce symptom burden in patients with newly diagnosed advanced pancreatic cancer (CanPan).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.2_suppl.697

Authors: Dylan M. Zylla, Ella Chrenka, Kendall Lin, Grace Gilmore, Jordan Cowger, David Rak, Arjun Gupta

Institutions: HealthPartners, University of Minnesota, Minnesota Department of Health

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7122532017

Cites:

Cited by:

Related to: 10